Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma.
In this study, we show that the hyaluronan synthase 1 (HAS1) gene undergoes aberrant intronic splicing in multiple myeloma (MM). In addition to HAS1 full length (HAS1(FL)), we identify 3 novel splice variants of HAS1, HAS1Va, HAS1Vb, and HAS1Vc, detected in patients with MM or monoclonal gammopathy of undetermined significance (MGUS). HAS1Vb and HAS1Vc undergo intronic splicing with creation of a premature stop codon. MM cells expressing one or more HAS1 variants synthesize extracellular and/or intracellular hyaluronan (HA). Expression of the HAS1Vb splice variant was significantly correlated with reduced survival (P = .001). Together, alternative HAS1 gene splicing, the correlations between HAS1 splicing and HA synthesis, and the correlations between HAS1 splicing and reduced survival of MM patients support the hypothesis that the family of HAS1 protein plays a significant role in disease progression. Further, expression of HAS1Vb, in conjunction with HAS1(FL) and/or other HAS1 variants, may lead to accumulation of intracellular HA molecules and an impact on receptor for HA-mediated motility (RHAMM)-mediated mitotic abnormalities in MM. This study highlights the potential importance of HAS1 and its alternative splicing in pathophysiology of MGUS and MM.
Adamia
Sophia
S
Department of Oncology, University of Alberta, and Cross Cancer Institute, Edmonton, Canada.
Reiman
Tony
T
Crainie
Mary
M
Mant
Michael J
MJ
Belch
Andrew R
AR
Pilarski
Linda M
LM
D017398:Alternative Splicing; D015153:Blotting, Western; D001853:Bone Marrow / Q000378:metabolism; D045744:Cell Line, Tumor; D003001:Cloning, Molecular; D003062:Codon; D018388:Codon, Terminator; D004247:DNA / Q000378:metabolism; D017931:DNA Primers / Q000737:chemistry; D019075:Electrophoresis, Capillary; D015972:Gene Expression Regulation, Neoplastic; D014453:Glucuronosyltransferase / Q000096:biosynthesis* / Q000235:genetics*; D006801:Humans; D000076002:Hyaluronan Synthases; D007438:Introns; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008938:Mitosis; D009101:Multiple Myeloma / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D010265:Paraproteinemias / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017422:Sequence Analysis, DNA; D013997:Time Factors; D016896:Treatment Outcome
D003062:Codon; D018388:Codon, Terminator; D017931:DNA Primers; D004247:DNA; D014453:Glucuronosyltransferase; D000076002:Hyaluronan Synthases
Cancer Lett. 1998 Sep 11;131(1):1-2
9839613
Blood. 1998 Oct 15;92(8):2844-55
9763569
Blood. 1999 Mar 1;93(5):1684-96
10029598
Hum Mutat. 1999;13(3):221-31
10090477
Cancer Res. 1999 May 15;59(10):2499-504
10344764
Blood. 1999 Jun 15;93(12):4144-8
10361111
J Biol Chem. 1999 Aug 27;274(35):25085-92
10455188
J Histochem Cytochem. 1999 Oct;47(10):1331-42
10490462
Cancer Res. 2005 Feb 1;65(3):850-60
15705883
Clin Cancer Res. 2000 Feb;6(2):585-96
10690543
Biochem J. 2000 May 15;348 Pt 1:29-35
10794710
Biochim Biophys Acta. 2000 Nov 15;1502(3):495-507
11068191
Cancer Res. 2001 Apr 1;61(7):3212-9
11306511
Oncogene. 2001 Jul 5;20(30):4041-9
11494132
Dis Markers. 2001;17(2):67-75
11673653
J Biol Chem. 2002 Mar 22;277(12):10050-7
11790779
J Biol Chem. 2002 May 17;277(20):18084-90
11834722
Cancer Cell. 2002 Jul;2(1):9-15
12150820
Cell Commun Adhes. 2002 May-Jun;9(3):117-30
12521133
Blood. 2003 Feb 15;101(4):1520-9
12393535
J Cell Physiol. 2003 Jun;195(3):356-72
12704645
Semin Oncol. 2003 Apr;30(2):165-8
12720129
Br J Haematol. 2003 Jun;121(5):749-57
12780789
Mol Biol Cell. 2003 Jun;14(6):2262-76
12808028
J Biol Chem. 2003 Jul 11;278(28):25285-8
12738783
J Biol Chem. 2003 Nov 21;278(47):47223-31
12954638
Rheumatology (Oxford). 2004 Feb;43(2):164-9
13130151
J Biol Chem. 2004 Apr 30;279(18):18679-87
14724275
J Cell Sci. 1991 Jun;99 ( Pt 2):227-35
1715873
Blood. 1992 Oct 1;80(7):1818-24
1391945
Hum Genet. 1992 Sep-Oct;90(1-2):41-54
1427786
Blood. 1993 Jan 15;81(2):446-53
7678518
Exp Cell Res. 1993 Aug;207(2):277-82
7688314
Curr Top Microbiol Immunol. 1995;194:17-24
7534667
Trends Biochem Sci. 1995 Nov;20(11):465-70
8578590
Blood. 1996 Mar 1;87(5):1891-9
8634437
Nat Med. 1996 Aug;2(8):912-7
8705862
Blood. 1997 Mar 1;89(5):1824-33
9057669
Blood. 1997 Nov 1;90(9):3751-9
9345062
Int J Cancer. 1997 Oct 21;74(5):477-81
9355968
J Biol Chem. 1998 Jan 23;273(4):1923-32
9442026
FEBS Lett. 1998 Dec 4;440(3):444-9
9872419